Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 1;79(5):465-473.
doi: 10.1093/jnen/nlaa014.

Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy

Kathryn Gauthreaux  1 , Tyler A Bonnett  2 , Lilah M Besser  3 , Willa D Brenowitz  4 , Merilee Teylan  1 , Charles Mock, Yen-Chi Chen  5 , Kwun C G Chan  1 , C Dirk Keene  6 , Xiao-Hua Zhou  1 , Walter A Kukull  1
Affiliations
Review

Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy

Kathryn Gauthreaux et al. J Neuropathol Exp Neurol. .

Abstract

It remains unclear what clinical features inform the accuracy of a clinical diagnosis of Alzheimer disease (AD). Data were obtained from the National Alzheimer's Coordinating Center to compare clinical and neuropathologic features among participants who did or did not have Alzheimer disease neuropathologic changes (ADNC) at autopsy. Participants (1854) had a clinical Alzheimer dementia diagnosis and ADNC at autopsy (Confirmed-AD), 204 participants had an AD diagnosis and no ADNC (AD-Mimics), and 253 participants had no AD diagnosis and ADNC (Unidentified-AD). Compared to Confirmed-AD participants, AD-Mimics had less severe cognitive impairment, while Unidentified-AD participants displayed more parkinsonian signs, depression, and behavioral problems. This study highlights the importance of developing a complete panel of biomarkers as a tool to inform clinical diagnoses, as clinical phenotypes that are typically associated with diseases other than AD may result in inaccurate diagnoses.

Keywords: Alzheimer disease; Diagnosis; Neuropathology.

PubMed Disclaimer

References

    1. Shim YS, Roe CM, Buckles VD, et al. Clinicopathologic study of Alzheimer’s disease: Alzheimer mimics. JAD 2013;35:799–811 - PMC - PubMed
    1. McKhann GM, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984;34:939–44 - PubMed
    1. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7:263–9 - PMC - PubMed
    1. Jack C, Bennett DA, Blennow K, et al. NIA-AA research framework: Toward a biological definition of Alzheimer’s disease. Alzheimers Dement 2018;14:535–62 - PMC - PubMed
    1. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7:280–92 - PMC - PubMed

Publication types

Grants and funding